[go: up one dir, main page]

BR0314362A - Método para previnir ou reduzir fraturas secundárias após fratura de quadril - Google Patents

Método para previnir ou reduzir fraturas secundárias após fratura de quadril

Info

Publication number
BR0314362A
BR0314362A BR0314362-7A BR0314362A BR0314362A BR 0314362 A BR0314362 A BR 0314362A BR 0314362 A BR0314362 A BR 0314362A BR 0314362 A BR0314362 A BR 0314362A
Authority
BR
Brazil
Prior art keywords
prevent
hip fracture
reduce secondary
treatment
secondary fractures
Prior art date
Application number
BR0314362-7A
Other languages
English (en)
Inventor
Kenneth W Lyles
Original Assignee
Novartis Ag
Kenneth W Lyles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31994241&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0314362(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag, Kenneth W Lyles filed Critical Novartis Ag
Publication of BR0314362A publication Critical patent/BR0314362A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)

Abstract

"MéTODO PARA PREVENIR OU REDUZIR FRATURAS SECUNDáRIAS APóS FRATURA DE QUADRIL". A presente invenção refere-se ao uso de um bisfosfonato na preparação de um medicamento para o tratamento de osteoporose pós-fratura de quadril para prevenir ou reduzir fraturas esqueléticas osteoporóticas subseq³entes em um paciente com necessidade desse tratamento, e, particularmente, a um paciente que sofreu reparo recente da fratura de quadril e a métodos de tratamento correspondentes.
BR0314362-7A 2002-09-16 2003-09-15 Método para previnir ou reduzir fraturas secundárias após fratura de quadril BR0314362A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41106702P 2002-09-16 2002-09-16
PCT/EP2003/010239 WO2004024166A1 (en) 2002-09-16 2003-09-15 Method for preventing or reducing secondary fractures after hip fracture

Publications (1)

Publication Number Publication Date
BR0314362A true BR0314362A (pt) 2005-07-19

Family

ID=31994241

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314362-7A BR0314362A (pt) 2002-09-16 2003-09-15 Método para previnir ou reduzir fraturas secundárias após fratura de quadril

Country Status (12)

Country Link
US (2) US20050272707A1 (pt)
EP (1) EP1542700B1 (pt)
JP (1) JP2006500402A (pt)
CN (1) CN1681516A (pt)
AT (1) ATE532523T1 (pt)
AU (1) AU2003270196A1 (pt)
BR (1) BR0314362A (pt)
CA (1) CA2497353C (pt)
ES (1) ES2376425T3 (pt)
PT (1) PT1542700E (pt)
TW (1) TWI344367B (pt)
WO (1) WO2004024166A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117906A1 (en) * 2004-05-19 2005-12-15 Merck & Co., Inc. Combination for inhibiting bone resorption comprising a bisphosponate (alendrona) and a vitamin d (cholecalciferol)
US8071574B2 (en) 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
EP1972341A1 (en) * 2007-03-23 2008-09-24 Novartis AG Pharmaceutical compositions comprising a bisphosphonate and vitamin D
CN102046152A (zh) * 2008-04-04 2011-05-04 诺瓦提斯公司 含有双膦酸盐的药物组合物
HUE025737T2 (en) * 2009-09-01 2016-05-30 Univ Duke Bisphosphonate compositions and methods for treating heart failure
US9949992B2 (en) 2011-11-16 2018-04-24 Duke University Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction
RU2540926C1 (ru) * 2013-09-23 2015-02-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ коррекции микроциркуляции в костной ткани при экспериментальном остеопорозе и переломах на его фоне l-норвалином
RU2538612C1 (ru) * 2013-09-23 2015-01-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ коррекции микроциркуляции в костной ткани при экспериментальном остеопорозе и переломах на его фоне розувастатином
RU2542425C1 (ru) * 2013-09-23 2015-02-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ коррекции микроциркуляции в костной ткани при экспериментальном остеопорозе и переломах на его фоне комбинацией l-аргинина и лозартана
RU2540927C1 (ru) * 2013-09-23 2015-02-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ коррекции микроциркуляции в костной ткани при экспериментальном остеопорозе и переломах на его фоне комбинацией l-норвалина и розувастатина
RU2542424C1 (ru) * 2013-09-23 2015-02-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ коррекции микроциркуляции в костной ткани при экспериментальном остеопорозе и переломах на его фоне комбинацией l-аргинина и эналаприла
ES2893753T3 (es) * 2016-05-20 2022-02-10 Christoph Karl Composiciones farmacéuticas con ácido zoledrónico, calcio y vitamina D, adecuadas para el tratamiento y/o la profilaxis de enfermedades del metabolismo óseo y de efectos secundarios inducidos por la terapia, tales como hipocalcemias

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3776880D1 (de) * 1986-11-21 1992-04-02 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
AU670337B2 (en) * 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
GB0012209D0 (en) * 2000-05-19 2000-07-12 Novartis Ag Organic compounds
HU228400B1 (en) * 2000-06-20 2013-03-28 Novartis Ag The use of bisphosphonates for treatment of osteoporosis

Also Published As

Publication number Publication date
JP2006500402A (ja) 2006-01-05
HK1079431A1 (en) 2006-04-07
ATE532523T1 (de) 2011-11-15
AU2003270196A1 (en) 2004-04-30
CA2497353C (en) 2012-08-28
EP1542700A1 (en) 2005-06-22
TWI344367B (en) 2011-07-01
PT1542700E (pt) 2012-02-01
CA2497353A1 (en) 2004-03-25
US20080193564A1 (en) 2008-08-14
US20050272707A1 (en) 2005-12-08
ES2376425T3 (es) 2012-03-13
WO2004024166A1 (en) 2004-03-25
TW200412979A (en) 2004-08-01
CN1681516A (zh) 2005-10-12
EP1542700B1 (en) 2011-11-09

Similar Documents

Publication Publication Date Title
WO2007120539A3 (en) Orthopedic device
WO2002087415A3 (en) Method of applying an active compressive force continuously across a fracture
ATE460893T1 (de) Orthopädische platten- und knochenschraubenanordnung
BR0318600A (pt) conjunto implantável para osteossìntese, e, conjunto com pelo menos duas placas de osteossìntese e parafusos ósseos
BR0314362A (pt) Método para previnir ou reduzir fraturas secundárias após fratura de quadril
BR9909445A (pt) Método para aumentar a rigidez e resistência óssea e reduzir fraturas
CA2495110A1 (en) Method and apparatus for repairing the mid-foot region via an intramedullary nail
WO2005086953A3 (en) Device and method for fixing bone segments
WO2005041812A3 (en) Implantable brace for a fracture and methods
WO2004019884A3 (en) Agents and methods for enhancing bone formation
WO2004044693A3 (en) System and process for matching patients with clinical medical trials
WO2008046405A3 (de) Behandlung von osteoporose
ATE443527T1 (de) 5-cnac zur oralen verabreichung von parathormonfragmenten
PL1682008T3 (pl) Stabilizator do leczenia złamań kości długiej
Seibert et al. External fixation in trauma of the foot and ankle
MX2007005525A (es) Tratamiento terapeutico de resorcion ose acelerada.
RU2010114106A (ru) Способ лечения перелома проксимального отдела плеча при тяжелой форме остеопороза
UA34163A (uk) Спосіб стимулювання остеогенезу при хірургічних втручаннях на кістках щелепи
UA36326A (uk) Пристрій для черезкісткового остеосинтезу поєднаних переломів таранної та п'яткової кісток
SAR Complex fractures of the tibia and femur treated with static interlocking intramedullary nail
UA33294A (uk) Спосіб реабілітації хворих після металоостеосинтезу внутрішньосуглобових переломів.
UA5996U (en) Method for surgical treatment of deforming arthrosis of the first metatarsophalangeal joint
MD257Z (ro) Metodă de tratament al deformaţiei de valgus a porţiunii proximale a femurului
MD2000G2 (ro) Metodă de reconstrucţie a fracturilor metafizare vicios consolidate de humerus distal la copii
SHENG et al. Treatment of unstable distal radial fractures with volar locking compression plate (LCP)

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2323 DE 14-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.